Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Beta blocking drugs in chronic obstructive bronchopneumopathies].

P Durandet1, P Gosse, J Vergeret

  • 1Service de Pneumologie, Hôpital du Haut-Lévêque, Centre Hospitalo-Universitaire de Bordeaux, Pessac.

Revue Des Maladies Respiratoires
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Chronic pheochromocytoma-induced myocardial injuries: What should we expect from modern and classical echocardiographic tools?]

Annales de cardiologie et d'angeiologie·2020
Same author

[Alteration of left ventricular longitudinal systolic function in 2D-strain in primary aldosteronism: A new target organ damage marker].

Annales de cardiologie et d'angeiologie·2018
Same author

Sleep disruptions increase arterial stiffness.

International journal of cardiology·2015
Same author

From malignant hypertension to hypertension-MOD: a modern definition for an old but still dangerous emergency.

Journal of human hypertension·2015
Same author

Malignant hypertension and interferon-beta: a case report.

Journal of human hypertension·2013
Same author

[After STAR and ASTRAL, let's go back on earth!].

Journal de radiologie·2011

Beta-blocker medications are useful for many conditions but can cause respiratory problems. Use with caution in patients with asthma or COPD, and avoid in allergic individuals.

Area of Science:

  • Pharmacology
  • Respiratory Medicine
  • Cardiology

Background:

  • Beta-blocker medications (beta-) are widely prescribed for cardiovascular, neurological, and ophthalmological conditions.
  • Respiratory tolerance can limit beta- blocker use, particularly in patients with underlying bronchial pathology.
  • Asthma and chronic obstructive pulmonary disease (COPD) are common comorbidities with conditions requiring beta- blockers.

Purpose of the Study:

  • To evaluate the respiratory risks associated with beta- blocker use.
  • To provide guidance on the safe prescription of beta- blockers in patients with respiratory conditions.

Main Methods:

  • Review of existing literature on beta- blocker effects on respiratory function.
  • Analysis of clinical scenarios involving beta- blockers and respiratory compromise.

Related Experiment Videos

Main Results:

  • Beta- adrenergic receptor blockade can precipitate bronchospasm in asthmatics and worsen airflow obstruction in COPD patients.
  • Cardioselectivity of beta- blockers is relative and dose-dependent, not eliminating respiratory risks.
  • Systemic and topical (e.g., eye drops) beta- blockers can induce respiratory adverse effects.

Conclusions:

  • Beta- blockers are contraindicated in COPD with bronchial hyper-reactivity.
  • In other cases, careful selection of cardioselective beta- blockers at the lowest effective dose is recommended.
  • Patients on beta- blockers require vigilant monitoring for respiratory side effects, and alternative treatments should be considered if symptoms arise.
  • Beta- blockers should be avoided in allergic subjects and during specific immunotherapy due to anaphylaxis risk.